Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

50.27
-1.1600-2.26%
Post-market: 50.500.2300+0.46%19:59 EDT
Volume:2.47M
Turnover:124.32M
Market Cap:101.68B
PE:16.08
High:51.03
Open:50.95
Low:50.17
Close:51.43
52wk High:61.70
52wk Low:38.63
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.93
T/O Rate:0.13%
Dividend:1.77
Dividend Rate:3.53%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.24
PE(LYR):13.45

Loading ...

Movement Alert|GSK Falls 3.02% in Regular Trading, Termination of Camlipixant Chronic Cough Program Marks $2 Billion Acquisition Pipeline Failure

Market Focus
·
Jul 21

GSK Updates Key Pediatric Flu Study, Signaling Quiet Upside for Its Antiviral Portfolio

TIPRANKS
·
Jul 21

GSK Falls Monday, Underperforms Market

Dow Jones
·
Jul 21

GSK announces EMA accepted submission to update Bexsero label

TIPRANKS
·
Jul 20

GSK Cough Drug Failure Disappoints, but Market was Cautious

Dow Jones
·
Jul 20

Dow Jones Top Company Headlines at 7 PM ET: Walmart Further Shuffles Top Executives | SpaceX ...

Dow Jones
·
Jul 18

GSK plc Stock (GSK) Moved Down by 3.06% on Jul 17: Drivers Behind the Movement

TradingKey
·
Jul 18

Movement Alert|GSK Falls 3.02% in Regular Trading, Discontinues Camlipixant Development After Phase 3 Failure in Refractory Chronic Cough

Market Focus
·
Jul 18

GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views

TIPRANKS
·
Jul 18

GSK Explores Heart Health Upside From Its Next-Gen Vaccines

TIPRANKS
·
Jul 18

GSK’s New Asthma Injection Study: Early Signals for Long-Term Investors

TIPRANKS
·
Jul 18

European Pharma Stocks' Underperformance Shouldn't Last

Dow Jones
·
Jul 17

GSK Oncology Portfolio Seems Underrated

Dow Jones
·
Jul 17

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Investors Retreat From Chipmaker Stocks

MT Newswires Live
·
Jul 17

Sector Update: Healthcare

MT Newswires Live
·
Jul 17

GlaxoSmithKline (GSK) Gets a Buy from Jefferies

TIPRANKS
·
Jul 17

GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment

Dow Jones
·
Jul 17

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

TIPRANKS
·
Jul 17

GSK Will Likely Need to Book Write-down on Cough Drug Failure

Dow Jones
·
Jul 17

GSK Stops Camlipixant Program in Refractory Chronic Cough After Phase 3 Data

MT Newswires Live
·
Jul 17